Diabetic Kidney Disease: A Report From an ADA Consensus Conference

Tuttle, Katherine R., Bakris, George L., Bilous, Rudolf W., Chiang, Jane L., de Boer, Ian H., Goldstein-Fuchs, Jordi, Hirsch, Irl B., Kalantar-Zadeh, Kamyar, Narva, Andrew S., Navaneethan, Sankar D., Neumiller, Joshua J., Patel, Uptal D., Ratner, Robert E., Whaley-Connell, Adam T., Molitch, Mark E.·2014·Diabetes Care
DOI 10.2337/dc14-1296

Cited by (1,000)

Items 901–1,000 of 1,000

  1. Heterogeneous Kidney Patterns in Diabetic Patients Following SGLT2 Inhibitor Use
    Sohyun Bae, Donghwan Yun, Jeeyoung Kim, Sehoon Park, Yong Chul Kim, Dong Ki Kim, Kook‐Hwan Oh, Kwon Wook Joo, Yon Su Kim, Seung Seok Han · 2026 · Journal of Korean Medical Science
  2. Typologies of Symptoms and Functions Among Patients With Chronic Kidney Disease and Population Characteristics: A Latent Profile Analysis
    Guoxiang Liu, Bei Yun, Xuanyi Bi, Qun Gu, Jinling Zhao, Jingting Wang · 2026 · Nursing Open
  3. Impact of visceral adiposity on glycemic variability in patients with insulin-treated type 2 diabetes undergoing hemodialysis
    Pedro Gil, Ascensión Lupianez-Barbero, Sònia Caparrós, Alicia Ribas, Shaira Martínez-Vaquera, Ángel Ortiz-Zúñiga, Cristina Hernández, Rafael Simó, Olga Simó‐Servat · 2026 · World Journal of Diabetes
  4. Development and internal validation of a machine-learning-based risk identification model for diabetic kidney disease in patients with type 2 diabetes
    Jianquan Luo, Guoxin Chen, Jiacheng Yang · 2026 · Frontiers in Endocrinology
  5. Diabetic Kidney Disease: A Call to Action: Preface
    Katherine R. Tuttle · 2015 · Diabetes Spectrum
  6. 2016 Prescott Lecture: Diabetes education—leadership through action
    Joshua J. Neumiller · 2016 · Journal of the American Pharmacists Association
  7. Antidiabetic Medication in Patients with Chronic Kidney Disease: What's New?
    Sara Dominijanni, Silvia Cipriani, Moreno Malaguti, Luigi Triolo, Ferruccio Ansali, Fulvio Floccari · 2017 · Nephrology Point of Care
  8. Combined effect of sodium–glucose cotransporter 2 and dipeptidyl peptidase‐4 inhibitors for diabetic kidney disease
    Shin‐ichi Araki · 2019 · Journal of Diabetes Investigation
  9. Renoprotection in diabetic kidney disease
    Michaël J.B. van Baar, Daniël H. van Raalte · 2019 · Current Opinion in Nephrology & Hypertension
  10. Prevalence of Hypoglycemia Among Type 2 Diabetics Undergoing Hemodialysis in a University Hospital
    Maria Concepcion H Gungon, Elaine C Cunanan · 2020 · Journal of Medicine University of Santo Tomas
  11. Diabetic Kidney Disease
    Ting Cai, Junwei Yang · 2019 · Springer eBooks
  12. Possibilities of using fosinopril in treatment of patients with chronic kidney disease in combination with cardiovascular diseases and diabetes mellitus
    Elizaveta Yu. Ebzeeva, Ol'ga Dmitrievna Ostroumova, Батюкина Светлана Владимировна, N. A. Shatalova, N. M. Doldo, R. R. Romanovsky · 2021 · Medical alphabet
  13. Diabetes Mellitus and Chronic Kidney Disease (Stages 1–5)
    Meaghan Elger, Arti Sharma Parpia, Dana Whitham · 2020 · Springer eBooks
  14. Association between COL4A3 variant rs55703767 and susceptibility to diabetic kidney disease in patients with type 2 diabetes mellitus: results from the INDEED cohort study
    Zihan Li, Zijun Sun, Dongyuan Chang, Li Zhu, Min Chen, Minghui Zhao · 2022 · Chinese Medical Journal
  15. Diabetic Nephropathy
    Maria Elba Bandeira de Farias, Deborah Queiroz, Fernanda Moura Victor · 2022 · Springer eBooks
  16. Efficacy and Safety of Tripterygium wilfordii Polyglycosides Versus Valsartan in Management of Diabetic Nephropathy
    You-Yun Wang, Ying-Lan Cheng, Jun-Lin Zhang · 2022 · International Journal of Pharmacology
  17. GLOMERULAR HYPERFILTRATION – CAUSES AND CONSEQUENCES
    2019 · Journal of the Medical Research Institute /Journal of Medical Research Institute
  18. Telmisartan combined with calcitriol enhances therapeutic efficacy for diabetic nephropathy while inhibiting inflammation and renal interstitial fibrosis.
    Daoman Xia, Jiana Zang · 2023 · PubMed Central
  19. Protective Effect of Trimetazidine on Kidney Dysfunction: A Review of Experimental Evidence
    Negin Amini, Mohammad Badavi · 2022 · Jundishapur Journal of Physiology.
  20. The Impact of Empagliflozin on Renal Function and Kidney Injury Markers in Patients with Diabetic Nephropathy
    Hadeel Delman Najim, Mohammed Mahmood Mohammed, Abbas Mahdi Rahmah · 2024 · Al-Rafidain Journal of Medical Sciences
  21. Comparative study of safflower yellow adjuvant to conventional treatment regimen and conventional treatment regimen on diabetic nephropathy
    Yun Liang, Xudong Chen, Sainan Luo, Yang Li · 2024 · Scientific Reports
  22. Factors Involved in the Development of Diabetic Kidney Disease in Patients With Slowly Progressive Type 1 Diabetes Mellitus: A Retrospective Cohort Study
    Hideyuki Okuma, Takahiro Tsutsumi, Masashi Ichijo, Tetsuro Kobayashi, Kyoichiro Tsuchiya · 2024 · Cureus
  23. Adherence to a healthful plant-based diet and risk of chronic kidney disease among individuals with diabetes: A prospective cohort study
    A. S. Thompson, Anna Tresserra‐Rimbau, Amy Jennings, Nicola P. Bondonno, Catharina J. Candussi, J. K. O’Neill, C. Hill, Martina Gaggl, Aedín Cassidy, Tilman E. Kuhn · 2024 · Proceedings of The Nutrition Society
  24. Diagnostic Potential of Dp‐ ucMGP as a Biomarker for Early Detection of Diabetic Kidney Disease in Patients With Type 2 Diabetes Mellitus: A Cross‐Sectional Study
    Farazul Hoda, Mawrah Arshad, Mohammad Ahmed Khan, Mohammad Anwar Habib, Abul Kalam Najmi · 2025 · Nephrology
  25. The impact of dynamic kidney function prior to using sodium–glucose cotransporter‐2 inhibitors in type 2 diabetes patients with low‐risk renal disease progression
    Yen‐Chen Chiu, Wanchana Singhan, Surarong Chinwong, Dujrudee Chinwong, Shang‐Jyh Hwang, Yaw‐Bin Huang · 2025 · Journal of Diabetes Investigation
  26. Diabetes Mellitus and Chronic Kidney Disease (Stages 1–5)
    Dana Whitham, Arti Sharma Parpia · 2013 · Humana Press eBooks
  27. Albuminuria and its associated biomedical factors among indigenous adults in Far North Queensland: a 7-year follow up study
    Ming Li, Robyn Anne McDermott · 2015 · BMC Nephrology
  28. The Clinical Utility of Urinary Microalbumin in the Management of Diabetes Mellitus
    Kent B Lewandrowski · 2017 · Point of Care The Journal of Near-Patient Testing & Technology
  29. New Tubulocentric Insights for Diabetic Nephropathy: From Pathophysiology to Treatment
    Sang Soo Kim, Jong Ho Kim, Su Mi Lee, Il Young Kim, Sang Heon Song · 2018 · InTech eBooks
  30. SGLT2 inhibitor and incretin mimetic therapy for type 2 diabetes and chronic kidney disease
    Katherine R. Tuttle · 2019 · The Lancet Diabetes & Endocrinology
  31. Regulatory T-cells dysregulation in type 2 diabetic nephropathy
    Walaa Hosny Mohammad Ibrahim, MostafaG Aly, AhmadB Ahmad, Noha Gaber Sayed, HebaS Galal, Muhammad H. Al-Maghraby · 2019 · Journal of The Egyptian Society of Nephrology and Transplantation
  32. The TUDID Study – Background and Design of a Prospective Cohort
    Benjamin Assad Jaghutriz, Robert J. Wagner, Stephanie Kullmann, Louise Fritsche, Sabine S. Eckstein, Corinna Dannecker, Caroline Willmann, Elko Randrianarisoa, Angela Lehn‐Stefan, Anja Hieronimus et al. · 2020 · Experimental and Clinical Endocrinology & Diabetes
  33. The Japanese Registries of Diabetic Nephropathy/Diabetic Kidney Disease
    Miho Shimizu, Takashi Wada · 2020 · Springer eBooks
  34. Coronavirus Disease-2019, Diabetes and Dialysis: An Internal Medicine Conundrum Proposal for a Suitable and Easy-to-Handle Prevention Protocol
    Felice Strollo, Ersilia Satta, Carmine Romano, Carmelo Alfarone, Teresa D. Corte, Giuseppina Guarino, Sandro Gentile · 2020 · Diabetes Research - Open Journal
  35. Cardioprotective and Renoprotective Effects of the Use of SGLT2 Inhibitors in Diabetes Mellitus Patients
    Linda Sukiatno, Ikhwan Yuda Kusuma, Galih Samodra · 2021 · International Conference on Health and Medical Sciences (AHMS)
  36. Role of type IV collagen in the development of diabetic nephropathy in patients with diabetes mellitus
    Angelina Kalmykova, Alfiya Emilevna Abdullina · 2020 · Medical news of the North Caucasus
  37. Putting it All Together: Practical Approach to the Patient with Diabetic Kidney Disease
    Eudora Eng, Susan E. Quaggin · 2022 · Springer eBooks
  38. Screening, Early Diagnosis, Genetic Markers and Predictors of Progression
    Jennifer A. Tuazon, Janis Cho · 2022 · Springer eBooks
  39. Effects of α lipoic acid combined with olmesartan medoxomil on blood glucose and oxidation indicators in patients with diabetic nephropathy
    Shengfu Jiao, Yuxia Dong, Xiang Chang, Yanan Wu, Haifeng Li · 2022 · Medicine
  40. Urinary Level of Tumor Necrosis Factor Alpha in Patients with Type –2 Diabetic Nephropathy
    Youssef Khalel Ahmed, Amin Mahmoud Amin Hegazy, Mohammed Abdel-Hamed Keder, Mohamed Ahmed Mohamed Moustafa · 2019 · The Egyptian Journal of Hospital Medicine
  41. Metformin-associated lactic acidosis (MALA) in a peritoneal dialysis patient
    Nam Ho Kim · 2021 · Medical Biological Science and Engineering
  42. Evaluation of Apelin-13 levels in patients with diabetic nephropathy
    Gamze İçen, Gülçin Dağlıoğlu, Mehtap Evran · 2022 · International Urology and Nephrology
  43. Study of Lipoprotein-Associated Phospholipase A2 as a Potential Biomarker for Diabetic Kidney Disease in Type 2 Diabetes
    Ibrahim M. Salem, Mabrouk Ibrahim Ismail, Adel Ghorab, Rabab Fouad, Osama Mosbah, Ghada Khalifa, Alaa Ahmed Abdelateef Ibraheem, Medhat Ibrahim Mahmoud, Nafesa M. Kamal · 2022 · The Egyptian Journal of Hospital Medicine
  44. Chronic Kidney Disease in Patients with Diabetes: Diabetic vs. Non-Diabetic Kidney Etiologies
    Gaosi Xu · 2022 · Journal of Diabetes Research Review & Reports
  45. Épidémiologie des maladies rénales chez les patients diabétiques et place des marqueurs
    S. Halimi · 2023 · Médecine des Maladies Métaboliques
  46. Efeito da insulina glargina sobre o controle glicêmico e risco de hipoglicemia em pacientes portadores de diabetes mellitus tipo 2 e doença renal crônica estágios 3 e 4: ensaio clínico, controlado e randomizado
    Carolina de Castro Rocha Betônico · 2017 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  47. Management of Diabetes and/or Hyperglycemia in Hospitalized Patients with Renal Insufficiency
    Glenn Matfin · 2018 · Wiley eBooks
  48. Angiotensin receptor neprolysin inhibitors: a novel approach to prevent cardiorenal disease in diabetes mellitus
    Adel E. Berbari · 2020 · Journal of Hypertension
  49. Effects of Blood Sugar Levels, Kidney Disease and Medication on Anaemia Status of Type 2 Diabetes Mellitus Patients
    Malala Mulavu, Mildred Zulu, Musalula Sinkala, Sody Mweetwa Munsaka, Pauline Okuku, Panji Nkhoma · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  50. Diabetes mellitus and the kidney
    Rudolf W. Bilous · 2020
  51. Hemoglobin, Albumin, Lymphocyte, and Platelet Score Correlates with the Occurrence and Prognosis of Diabetic Kidney Disease Patients: Data from Two Large Cohorts
    Lingzhi Xing, Fang Xi Xie, Zuorong Zhong, BaiYuLu Chen, Wenqing Li, Yingdan Zhang, Li‐Yuan Chen, Letai Li, Letai Li, LeZhi Wang et al. · 2024 · Preprints.org
  52. Type 2 diabetes amplifies environmental Pb toxicity and intergenerational risk
    Chen Zhang, Xiaoping Xia, Chen Zhang, Chenyu Pei, Zhixiang Guo, Guangnan Li, Liang Xu, Huali Luo, Jiaoyan Ma, Jingwen Luo et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  53. Microalbumin: Urinary Biomarker of Cardiovascular Risk Assessment
    Tabassum Samad, Wasim Md Mohosin Ul Haque · 2016 · BIRDEM Medical Journal
  54. Glucose‐lowering drugs
    Andrew J. Krentz, Alan J. Sinclair · 2017 · Wiley eBooks
  55. Diabetic Nephropathy: Where do we Stand
    Chandra Mauli Jha · 2017 · Urology & Nephrology Open Access Journal
  56. Inzidenz der diabetischen Nephropathie
    Michael Jecht · 2017 · Der Diabetologe
  57. Néphropathie diabétique: macroalbuminurie, insuffisance rénale
    S. Halimi · 2017
  58. Physical activity and lifestyle behaviours in obesity and the prevention of type 2 diabetes: The PREVIEW Project
    Nils J. Swindell · 2018 · Cronfa (Swansea University)
  59. Associação de uma tabela de contagem de fósforo com cloridrato de sevelamer para controle da hiperfosfatemia em pacientes em hemodiális
    Vivianne Rêis Bertonsello · 2018 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  60. Diabetic Pharmacotherapies in Kidney Disease
    Deborah A. Chon, Rachael T. Oxman, RASHMI S. MULLUR, Jane Eileen Weinreb · 2019 · Springer eBooks
  61. Glycemic Metrics and Targets in Kidney Disease
    Joshua J. Neumiller, Irl B. Hirsch · 2019 · Springer eBooks
  62. The Role of Courage in the Experience of Patients with Diabetes Complications
    Patricia Donohue-Porter · 2019
  63. Renoprotective Effects of SGLT2 Inhibitors
    Cristian Guja, Rucsandra Dănciulescu Miulescu · 2019 · Romanian Journal of Diabetes Nutrition and Metabolic Diseases
  64. Diabetic kidney disease: seven questions
    Dong Ho Yang, So‐Young Lee · 2020 · Journal of Korean Medical Association
  65. Combined Antithrombotic Therapy in Patients with a Stable Atherosclerotic Cardiovascular Diseases: What Direction did COMPASS Show?
    С. Г. Канорский · 2020 · Kardiologiia
  66. The Relation between Microvascular Complications of Type II Diabetes with Levels of Serum Progranulin.
    Rania El-Sayed Sheir, Mohamed Nabil Salem, Mohamed Mamdouh, Rehab AbdelKarem · 2020 · Egyptian Journal of Medical Research
  67. Correlation between Residual Renal Function and Hypertension in Regular Haemodialysis Patients
    Said Sayed Ahmed Khamis, Yassein Salah Yassein, Nahla El-Ghalban, Hany Said Elbarbary · 2020 · Open Journal of Nephrology
  68. Prescribing trends, utilisation and comparative effectiveness of antidiabetic drug therapies prescribed in UK primary care
    Samantha Wilkinson · 2020 · LSHTM Research Online (London School of Hygiene and Tropical Medicine)
  69. Chronic Kidney Disease, Common Comorbidities, and Diabetes
    Branden D. Nemecek · 2019 · ASHP eBooks
  70. Management of Diabetes Mellitus in Acute and Chronic Cardiorenal Syndromes
    Allison J Hahr, Mark E. Molitch · 2020 · Springer eBooks
  71. When and how to Use Prandial Insulin with Ultralong-Acting Basal Insulin in T2Dm
    Guillermo E. Umpierrez · 2016 · Endocrine Practice
  72. When and how to Use Ultralong-Acting Basal Insulin in T2Dm
    Alan J. Garber · 2016 · Endocrine Practice
  73. When and how to Use A Glp-1 ra With Long- or Ultralong-Acting Basal Insulin in T2Dm
    Bruce W. Bode · 2016 · Endocrine Practice
  74. Coronavirus Disease-2019, Diabetes and Dialysis in Southern Italy: The Second Wave Follow-up
    Felice Strollo, Ersilia Satta, Carmine Romano, Carmelo Alfarone, Teresa Della Corte, Giuseppina Guarino, Maria Pasquarella, Sandro Gentile · 2020 · Diabetes Research - Open Journal
  75. Network Pharmacology-Based Investigation into the Mechanisms of Qibangyishen Formula for the Treatment of Diabetic Kidney Disease
    Zhi Wang, Guihua Jian · 2021 · Research Square
  76. Relation between 25-Hydroxyvitamin D, Systemic Inflammation and Endothelial Function Biomarkers in Diabetic Nephropathy
    Mohammed H Saiem Al-Dahr · 2020 · Gastroenterology Medicine & Research
  77. Early Manifestations of Acute Renal Failure in a Pregnant Woman with Diabetes
    Behjat Khorsandi, Mahsa Khoshnam Rad, Maryam Moradi, Fatemeh Mohammadnejad · 2020 · Journal of Clinical and Basic Research
  78. The History of Insulin Technology: A Brief Review of the Updates in Basal Insulin Therapy Through the Years
    Alan J. Garber · 2016 · Endocrine Practice
  79. Diabetes, the kidney and the heart-A tale of metabolic mayhem
    Javier Morales, Merces Assumpcao‐Morales · 2021 · Journal of Cardiology & Current Research
  80. Risk Factors for Cardiovascular and Renal Disease in Type 2 Diabetes Mellitus in Patients with Normal and Mildly Reduced Glomerular Filtration Rate
    Stoiţă Marcel, Amorin Remus Popa · 2021 · Internal Medicine
  81. Diabetes Management in the Elderly Patient with Kidney Disease
    Mark E. Molitch · 2015
  82. Evaluation of Oxidative Stress Parameters and Lipid Profile in Diabetic Nephropathy Patients
    Yadav Bhuneshwar, Kurpad Nagaraj Shashidhar, Anjanappa Raveesh, Muninarayana Chandrappa · 2021 · International Journal of Current Research and Review
  83. The role of glycoproteins in glomerular pathophysiology
    Alina Khramova · 2021 · Gothenburg University Publications Electronic Archive (Gothenburg University)
  84. The Natural History of Diabetic Kidney Disease and Treatment of Hyperglycemia in Patients with Type 2 Diabetes
    Nsunaik Marik · 2021
  85. Value of 2 risk prediction models in predicting the risk of atherosclerosis in patients with chronic kidney disease.
    Shengnan Chen, Ning Li, Yan Shen · 2021 · PubMed Central
  86. Diabetes mellitus type 2 does not influence carotid stiffness in patients on maintenance hemodialysis
    Konrad Rekucki, Agnieszka Sławuta, Marta Obremska, Katarzyna Madziarska · 2021 · Postępy Higieny i Medycyny Doświadczalnej
  87. Comparative study on the influence of L carnitine and/or fenofibrate against streptozotocin induced diabetic nephropathy: role of TGF-β1/Smad Signaling Pathway.
    Amany A. Alzokaky, Nahed A. Raslan, Nayira A. Abdel Baky · 2021 · Azhar International Journal of Pharmaceutical and Medical Sciences/Azhar International Journal of Pharmaceutical and Medical Sciences
  88. Diabetic Nephropathy
    Luigi Gnudi, Sally M. Marshall · 2022
  89. MR Elastography
    Patrick J. Navin, Sudhakar Kundapur Venkatesh, Richard L. Ehman · 2021 · Elsevier eBooks
  90. Peer Review #2 of "Cardiovascular manifestations of renovascular hypertension in diabetic mice (v0.1)"
    2016 · PeerJ
  91. New Clinical Initiatives at the Steno Diabetes Center Odense and in the Region of Southern Denmark
    Michael Einar Røder · 2019 · Archives of Diabetes & Obesity
  92. Peer Review #1 of "Cardiovascular manifestations of renovascular hypertension in diabetic mice (v0.3)"
    2016 · PeerJ
  93. Peer Review #2 of "Cardiovascular manifestations of renovascular hypertension in diabetic mice (v0.2)"
    2016 · PeerJ
  94. Significance of Young’s Modulus and BMP-7 in the Diagnosis of Different Stages of Diabetic Nephropathy
    靓 张 · 2021 · Advances in Clinical Medicine
  95. An Update of the Diagnosis for Diabetic Kidney Disease (Preprint)
    Gaosi Xu, Qi Wang · 2020
  96. Peer Review #1 of "Cardiovascular manifestations of renovascular hypertension in diabetic mice (v0.2)"
    2016 · PeerJ
  97. STUDY ON EFFECT OF AYURVEDIC TREATMENT TO STABILIZE CREATININE LEVEL AND CONTROL PROGRESSION OF CHRONIC KIDNEY DISEASE
    2020 · International Ayurvedic Medical Journal
  98. Causes of Hypoglycemia
    Ala’ Abu-Odeh, Dalal Alnatour, Leen Fino · 2022 · IntechOpen eBooks
  99. Serum ferritin level in type 2 diabetic patients with renal dysfunction
    Prashanthkumar Goudappala, Jasneet Sandhu, Vinay Krishnaiah, Siva Prasad Palem · 2022 · IMC Journal of Medical Science
  100. CORRELATION BETWEEN CAROTID INTIMA-MEDIA THICKNESS WITH URINE ALBUMIN CREATININE RATIO IN PATIENTS WITH TYPE 2 DABETES MELLITUS
    Ourangajeb Ourangajeb, Md. Earshad Ali · 2022 · Indian Journal Of Applied Research